Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Psoriasis Drugs Market, by region, 2019-2027 (USD Billion)
1.2.2. Psoriasis Drugs Market, by Treatment type, 2019-2027 (USD Billion)
1.2.3. Psoriasis Drugs Market, by Mechanism of action, 2019-2027 (USD Billion)
1.2.4. Psoriasis Drugs Market, by Role of administration, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Psoriasis Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Psoriasis Drugs Market Dynamics
3.1. Psoriasis Drugs Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Need for efficient and long-lasting drugs
3.1.1.2. Increase in disease burden and demand for psoriasis medication
3.1.2. Market Restraint
3.1.2.1. Potential side-effects of existing medication
3.1.2.2. Extensive drug development and approval process
3.1.3. Market Opportunities
3.1.3.1. Increasing prevalence of psoriasis diseases
3.1.3.2. Favourable government initiatives
Chapter 4. Global Psoriasis Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Psoriasis Drugs Market, by Treatment type
5.1. Market Snapshot
5.2. Global Psoriasis Drugs Market by Treatment type, Performance - Potential Analysis
5.3. Global Psoriasis Drugs Market Estimates & Forecasts by Treatment type 2018-2027 (USD Billion)
5.4. Psoriasis Drugs Market, Sub Segment Analysis
5.4.1. Biologic Drugs
5.4.2. Small Molecule Systemic Drugs
5.4.3. Tropical Therapies
Chapter 6. Global Psoriasis Drugs Market, by Mechanism of action
6.1. Market Snapshot
6.2. Global Psoriasis Drugs Market by Mechanism of action, Performance - Potential Analysis
6.3. Global Psoriasis Drugs Market Estimates & Forecasts by Mechanism of action 2018-2027 (USD Billion)
6.4. Psoriasis Drugs Market, Sub Segment Analysis
6.4.1. TNF Alpha Inhibitors
6.4.2. PDE4 Inhibitors
6.4.3. Interleukin Inhibitors
6.4.4. Other Mechanisms of Action
Chapter 7. Global Psoriasis Drugs Market, by Role of administration
7.1. Market Snapshot
7.2. Global Psoriasis Drugs Market by Role of administration, Performance - Potential Analysis
7.3. Global Psoriasis Drugs Market Estimates & Forecasts by Role of administration 2018-2027 (USD Billion)
7.4. Psoriasis Drugs Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Parenteral
7.4.3. Topical
Chapter 8. Global Psoriasis Drugs Market, Regional Analysis
8.1. Psoriasis Drugs Market, Regional Market Snapshot
8.2. North America Psoriasis Drugs Market
8.2.1. U.S. Psoriasis Drugs Market
8.2.1.1. Treatment type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Mechanism of action breakdown estimates & forecasts, 2018-2027
8.2.1.3. Route of administration breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Psoriasis Drugs Market
8.3. Europe Psoriasis Drugs Market Snapshot
8.3.1. U.K. Psoriasis Drugs Market
8.3.2. Germany Psoriasis Drugs Market
8.3.3. France Psoriasis Drugs Market
8.3.4. Spain Psoriasis Drugs Market
8.3.5. Italy Psoriasis Drugs Market
8.3.6. Rest of Europe Psoriasis Drugs Market
8.4. Asia-Pacific Psoriasis Drugs Market Snapshot
8.4.1. China Psoriasis Drugs Market
8.4.2. India Psoriasis Drugs Market
8.4.3. Japan Psoriasis Drugs Market
8.4.4. Australia Psoriasis Drugs Market
8.4.5. South Korea Psoriasis Drugs Market
8.4.6. Rest of Asia Pacific Psoriasis Drugs Market
8.5. Latin America Psoriasis Drugs Market Snapshot
8.5.1. Brazil Psoriasis Drugs Market
8.5.2. Mexico Psoriasis Drugs Market
8.6. Rest of The World Psoriasis Drugs Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amgen Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. AstraZeneca
9.2.3. Biogen Idec
9.2.4. Novartis AG
9.2.5. Celgene Corporation
9.2.6. Dr. Reddy's Laboratories
9.2.7. Sun Pharmaceuticals Industries Limited
9.2.8. Pfizer Inc
9.2.9. Johnson & Johnson
9.2.10. Eli Lilly Company
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption